Starfish medical icon only logo
Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Jet Injector Drug Delivery: Promise and Pitfalls

YouTube video thumbnail

Jet injectors push liquid drug through the skin without a needle, and the idea has been around since the 1960s, the same era that gave us the hypo spray on Star Trek. Decades later, jet injectors are still on the market, and on this episode of Bio Break, Nick Allan and Nigel Syrotuck weigh why they have stuck around, and where they still fall short.

Why jet injectors are still around

The appeal comes down to two things: ease of use, and less pain than a syringe or microneedle. The logic is straightforward. Pain scales with the combined diameter of the needle and the drug moving through it, so a wider needle means a more painful injection. Remove the metal needle entirely and replace it with a pressurized stream of liquid, and in theory, the injection hurts less.

The shear problem behind jet injector drug delivery

The word “jet” is also where the concerns start. A jet implies a spray, or at least something delivered under real pressure, and pressure raises the question of shear. That matters most for drugs like mRNA vaccines, which rely on lipid nanoparticles to protect the mRNA payload. If that particle gets sheared apart during injection, the payload is left exposed. That is one reason some drugs are effectively incompatible with jet injectors.

The tradeoffs that remain

Side spray is another practical issue, since it can waste drug during the injection. And because the injector’s capital equipment, the “gun” itself, is reused across patients rather than disposed of, cross-contamination is an ongoing challenge that has to be managed through sterilization and wipe-down protocols between uses.

Even with these tradeoffs, jet injectors remain a going concern in drug delivery. They are not a universal replacement for needles, but for the right drug and the right use case, they still solve a real problem: getting a dose in with less pain and no sharp to dispose of. The hosts close the episode with a simple verdict: jet injectors are still flying high.

What this episode covers

  • How jet injectors deliver drugs without a needle, and how long the technology has existed
  • Why removing the needle is theorized to reduce injection pain
  • How the pressurized delivery mechanism raises shear concerns for certain drug formulations
  • Why mRNA vaccines packaged in lipid nanoparticles may be incompatible with jet injection
  • The practical drawbacks of side spray and drug waste during injection
  • Why reusable injector hardware creates an ongoing cross-contamination management challenge
  • Why jet injectors remain commercially viable despite these limitations

Learn more about StarFish Medical.

Businessman holding a glowing compliance icon with legal and regulatory symbols, representing REACH SVHC compliance for medical device manufacturers

MPO: REACH SVHC Compliance for Medical Device Makers

Nigel Syrotuck breaks down REACH SVHC compliance for teams working with material suppliers and compliance questionnaires.

Medical Device Design Simulation

MD+DI: Medical Device Simulation Strategy That Works

We examine when computational modelling and simulation, or CM&S, genuinely supports medical device simulation strategy and when it becomes a costly detour.

Transparent medical device prototype surrounded by computational simulation mesh representing modeling and simulation during medical device development.

Building Better Medical Devices Faster: The Strategic Role of CM&S

Many teams still underuse CM&S, often bringing it late in device validation, when key decisions have already been made. That approach leaves much of the value of CM&S untapped.

Biomedical engineer reviewing a thermal simulation of human head tissue on a monitor, color-mapped from warm to cool gradients

Bioheat Transfer in Living Tissue: History, Models, and Engineering Applications

This article traces the Pennes bioheat equation from its 1948 origins to modern multiscale approaches, explaining how engineers select the right level of modelling complexity across device categories.